4. In the March 2019 quarterly financial statements, there does not appear to be any revenue received from Mabsut Life despite the announcement in November 2017 stating 'Under the agreement MXC will supply a specialised CBD extract to Mabsut Life at a minimum of 12kg of CBD extract per quarter'. Can MGC explain why there does not appear to be any revenue received from Mabsut Life in this March 2019 quarter?
Ann: Brazil Distribution Agreement signed for MGC Pharma Products, page-52
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.73M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4408 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 1899 | 2 |
View Market Depth
| Last trade - 16.12pm 08/11/2024 (20 minute delay) ? |
| RGT (ASX) Chart |
Day chart unavailable